Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma

Invasive lobular breast carcinoma (ILC) accounts for 10% to 15% of breast cancers diagnosed annually. Evidence suggests that some aspects of endocrine treatment response might differ between invasive ductal carcinoma (IDC) and ILC, and that patients with ILC have worse long-term survival. We analyze...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinology
Autors principals: Sreekumar, Sreeja, Levine, Kevin M, Sikora, Matthew J, Chen, Jian, Tasdemir, Nilgun, Carter, Dorothy, Dabbs, David J, Meier, Carolin, Basudan, Ahmed, Boone, David, McAuliffe, Priscilla F, Jankowitz, Rachel C, Lee, Adrian V, Atkinson, Jennifer M, Oesterreich, Steffi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7438704/
https://ncbi.nlm.nih.gov/pubmed/32609836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/endocr/bqaa109
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars